Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of a Multi-Pathway Dietary Supplement (Stem Cell 100+) on Indices of Health and Life Expectancy

NCT03052491 is registered in ClinicalTrials.gov with Centagen, Inc. as lead sponsor.

NCT NCT03052491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03052491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of a Multi-Pathway Dietary Supplement (Stem Cell 100+) on Indices of Health and Life Expectancy
Lead sponsor
Centagen, Inc.
Phase
Not applicable
Overall status
Completed
Start date
March 12, 2016
Completion date
August 24, 2016
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure, concentration ability impaired, energy supply; deficiency, hdl low, immune deficiency, joint instability, lung function decreased, quality of life, stress